First Light Develops Screening to Prevent Infections

1 Mins read

First Light Biosciences is a development stage company developing novel medical diagnostic products for preventing and detecting healthcare associated infections. The company’s MultiPath technology, which uses digital imaging to count cells and molecules without magnification, enables sensitivity comparable to genetic diagnostics but with improved cost-effectiveness, ease-of-use, and automation. The company aims to be the first to enable any hospital to afford to use rapid screening to prevent hospital infections caused by bacterial agents such as MRSA. The company’s products can be used to detect a broad range of infectious disease targets, including antibiotic resistant bacteria, toxins, viruses, and biomarkers. Automation of sophisticated diagnostics expands the use of the most advanced techniques throughout the scope of health care facilities, from large laboratories to small doctor’s offices, thereby ensuring that all patients receive the best care possible.

Related posts

How Rapid Blood Testing Solves Blood Lab Wait Time Issues

3 Mins read
In early November 2020, Steven Hill* experienced a concerning and prolonged bout of nausea, weakness, and a host of other symptoms that…
Health careMedical DevicesTechnology

Can Medical Devices Help Reduce the Cost of Healthcare?

8 Mins read
Healthcare costs are on the rise; according to CNN Money, a 2016 report reveals the huge cost gap between the early 2000s…
AddictionAddiction RecoveryMental HealthTechnology

Having an Addiction Problem? Counseling Definitely Help!

5 Mins read
When you think of addiction, you’re likely picturing classic film and tv portrayals of the typical “junkie.” Unfortunately, the world doesn’t always…